Carregant...
地西他滨治疗骨髓增生异常综合征及相关肿瘤的疗效预测因素研究
OBJECTIVE: To identify clinical and molecular signatures for predicting response to decitabine (DAC) in patients with myelodysplastic syndrome (MDS) and related neoplasms. METHODS: The clinical characteristics of 109 patients with MDS and related neoplasms who were treated with DAC were analyzed ret...
Guardat en:
| Publicat a: | Zhonghua Xue Ye Xue Za Zhi |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Editorial office of Chinese Journal of Hematology
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7354175/ https://ncbi.nlm.nih.gov/pubmed/28279036 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3760/cma.j.issn.0253-2727.2017.02.008 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|